Arcturus Therapeutics is actively engaged in partnering discussions. Please contact BD@ArcturusRx.com regarding any business development opportunities.
August 4, 2020
Arcturus Therapeutics to Report Second Quarter 2020 Financial Results and Provide Corporate Update on August 10, 2020
July 31, 2020
Arcturus Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
July 29, 2020
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock